HCmed Innovations Co., Ltd., in collaboration with one of the world's top 10 pharmaceutical companies, has officially launched its vibrating mesh nebulizer, Deepro, in the Federative Republic of Brazil.

HCmed Innovations (HCmed) confirmed on December 27, 2017, that Vivo capital, through the fund under its management, PANDA Fund, L.P., has become its strategic investor.

Deepro is ready to blow your mind by its incredibly chic look and superior performance!

As inquiries regarding Deepro keep increasing, HCMedi thirsts for more conversations.

No more worries about medication leakage during nebulization. Register now to join the delightful experience with us, and win a free gift.

Nebulization is a time-tested approach for delivering aerosol to targeted pulmonary areas, especially for inhalation therapies that require deep lung deposition.

The principle of nebulizer therapy can be tracked as far back as 4000 years ago. Since the earliest days of recorded human history, people have been suffering from throat and chest pains.

The number of people suffering from asthma has exploded since the 1970s and continues to grow every year.